Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

Last updated:
2026-08-01
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL, ASSESSING THE IMPACT OF INCLISIRAN ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PARTICIPANTS WITH ESTABLISHED CARDIOVASCULAR DISEASE (VICTORION-2 PREVENT)

Intervention/treatment:
INCLISIRAN (KJX839)
Medical condition:
CARDIOVASCULAR DISEASE
Protocol code:
CKJX839B12302
Control number:
256429
Status:
Active, not recruiting
Approved:
October 18, 2021
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT05030428
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
40 Years to 100 Years
Accepts healthy volunteers: No

Contacts and locations

Contact
Sponsor
NOVARTIS PHARMACEUTICALS CANADA INC

Locations

Alberta

Novartis Investigative Site
Calgary, Alberta, T2N 4N1
Novartis Investigative Site
Edmonton, Alberta, T5H 4B9
Novartis Investigative Site
Edmonton, Alberta, T6K 4C1

British Columbia

Novartis Investigative Site
Longueuil, British Columbia, J4H 4B9
Novartis Investigative Site
North Vancouver, British Columbia, V7M 2H4
Novartis Investigative Site
Vancouver, British Columbia, V5Z 1M9
Novartis Investigative Site
Vancouver, British Columbia, V6Z 1Y6
Novartis Investigative Site
Victoria, British Columbia, V8R4R2
Novartis Investigative Site
Victoria, British Columbia, V8T 5G4
Novartis Investigative Site
Victoria, British Columbia, V8V 4A1

Manitoba

Novartis Investigative Site
Winnipeg, Manitoba, R3C 0N2
Novartis Investigative Site
Winnipeg, Manitoba, R3L 1Z5

New Brunswick

Novartis Investigative Site
Moncton, New Brunswick, E1G 1A7

Nova Scotia

Novartis Investigative Site
Halifax, Nova Scotia, B3H 2Y9
Novartis Investigative Site
Sydney, Nova Scotia, B1P 1P3

Ontario

Novartis Investigative Site
Cambridge, Ontario, N1R 7R1
Novartis Investigative Site
Guelph, Ontario, N1H 1B1
Novartis Investigative Site
Newmarket, Ontario, L3Y 2P6
Novartis Investigative Site
Oakville, Ontario, L6K 3W7
Novartis Investigative Site
Peterborough, Ontario, K9J 0B2
Novartis Investigative Site
Sarnia, Ontario, N7T 4X3
Novartis Investigative Site
Scarborough Village, Ontario, M1B 4Z8
Novartis Investigative Site
Scarborough Village, Ontario, M1B 5N1
Novartis Investigative Site
Stoufville, Ontario, L4A 1H2

Quebec

Novartis Investigative Site
Montreal, Quebec, H2X 1R9
Novartis Investigative Site
Montreal, Quebec, H3M 1L3
Novartis Investigative Site
Montreal, Quebec, H4N 2W2
Novartis Investigative Site
Québec, Quebec, G1V 4G5
Novartis Investigative Site
Québec, Quebec, G1W 4R4
Novartis Investigative Site
Québec, Quebec, G2J 0C4
Novartis Investigative Site
Saint-Jérôme, Quebec, J7Z 5T3
Novartis Investigative Site
Sainte-Foy, Quebec, G1V 4G2
Novartis Investigative Site
Terrebonne, Quebec, J6V 2H2
Novartis Investigative Site
Trois-Rivières, Quebec, G8Z 3R9
Did you find what you were looking for?